—

Kiniksa Pharmaceuticals Ltd (KNSA) — the peer cohort

As of 2026-11-19 — scores re-bake nightly. Cohort = shared Closelooknet index membership first, then sector. Diary readings, not advice.

Kiniksa Pharmaceuticals Ltd ranks 3 of 7 in its cohort on the Closelooknet composite (58/100) — the cohort is led by Laboratorios Farmaceuticos ROVI at 63/100.

NameCompositeMomentumQualityValuationSignalOff 52w high
KNSA Kiniksa Pharmaceuticals Ltd 58 95 61 17 ok 5.8%
ROVI.MC Laboratorios Farmaceuticos ROVI 63 60 74 42 info 22.4%
LNTH Lantheus Holdings Inc 60 77 73 53 ok 8.7%
IRWD Ironwood Pharmaceuticals Inc 58 75 77 82 info 18.5%
GALDY GALDERMA GROUP AG 56 70 59 21 ok 8.9%
BHC.TO Bausch Health Companies Inc 55 96 50 84 ok 2.8%
FAGR.BR Fagron NV 55 71 55 56 ok 3.6%

Scores are relative readings across the Closelooknet coverage universe — methodology in the company-scoring explainer. Signal lights come from the nightly signal board.

FAQ · from the current data · as of 2026-11-19

Quick answers

Who are Kiniksa Pharmaceuticals Ltd's peers in the Closelooknet universe?

The cohort is drawn from shared Closelooknet index membership first, then sector: Laboratorios Farmaceuticos ROVI (ROVI.MC), Lantheus Holdings Inc (LNTH), Ironwood Pharmaceuticals Inc (IRWD), GALDERMA GROUP AG (GALDY), Bausch Health Companies Inc (BHC.TO), Fagron NV (FAGR.BR), as of 2026-11-19.

How does KNSA score against its peers?

Kiniksa Pharmaceuticals Ltd's composite reads 58/100, ranking 3 of 7 in its cohort as of 2026-11-19; the cohort's highest composite is Laboratorios Farmaceuticos ROVI at 63/100. Closelooknet scores are research diary readings, not ratings or advice.

Related in the Closelooknet universe

then Drug Manufacturers - Specialty & Generic. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.